ATE487718T1 - Substituierte bizyklische pyrimidonderivate - Google Patents

Substituierte bizyklische pyrimidonderivate

Info

Publication number
ATE487718T1
ATE487718T1 AT06847275T AT06847275T ATE487718T1 AT E487718 T1 ATE487718 T1 AT E487718T1 AT 06847275 T AT06847275 T AT 06847275T AT 06847275 T AT06847275 T AT 06847275T AT E487718 T1 ATE487718 T1 AT E487718T1
Authority
AT
Austria
Prior art keywords
bizyclic
substituted
pyrimidone derivatives
pyrimidone
derivatives
Prior art date
Application number
AT06847275T
Other languages
English (en)
Inventor
Nathalie Chereze
Alistair Lochead
Mourad Saady
Franck Slowinski
Philippe Yaiche
Original Assignee
Sanofi Aventis
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis, Mitsubishi Tanabe Pharma Corp filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE487718T1 publication Critical patent/ATE487718T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
AT06847275T 2005-11-21 2006-11-21 Substituierte bizyklische pyrimidonderivate ATE487718T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05292457A EP1790649A1 (de) 2005-11-21 2005-11-21 Substituierte bicyclische Pyrimidone Derivaten
PCT/IB2006/004046 WO2007057790A2 (en) 2005-11-21 2006-11-21 Substituted bicyclic pyrimidone derivatives

Publications (1)

Publication Number Publication Date
ATE487718T1 true ATE487718T1 (de) 2010-11-15

Family

ID=35659035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06847275T ATE487718T1 (de) 2005-11-21 2006-11-21 Substituierte bizyklische pyrimidonderivate

Country Status (24)

Country Link
US (2) US8148364B2 (de)
EP (2) EP1790649A1 (de)
JP (1) JP5124471B2 (de)
KR (1) KR20080070671A (de)
CN (1) CN101312971B (de)
AR (1) AR057906A1 (de)
AT (1) ATE487718T1 (de)
BR (1) BRPI0618752A2 (de)
CA (1) CA2630360A1 (de)
CY (1) CY1111125T1 (de)
DE (1) DE602006018190D1 (de)
DK (1) DK1957492T3 (de)
EA (1) EA014918B1 (de)
ES (1) ES2355756T3 (de)
HR (1) HRP20100724T1 (de)
IL (1) IL191213A (de)
MX (1) MX2008006321A (de)
NZ (1) NZ568014A (de)
PL (1) PL1957492T3 (de)
PT (1) PT1957492E (de)
RS (1) RS51654B (de)
SI (1) SI1957492T1 (de)
WO (1) WO2007057790A2 (de)
ZA (1) ZA200804335B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992620A1 (de) * 2007-05-16 2008-11-19 Sanofi-Aventis Arylamid-Pyrimidon-Derivate zur Behandlung von neurodegenerativen Krankheiten
EP1992625A1 (de) 2007-05-16 2008-11-19 Sanofi-Aventis Arylamid-Pyrimidon-Verbindungen
EP1992624A1 (de) 2007-05-16 2008-11-19 Sanofi-Aventis Heteroarylamid-Pyrimidon-Verbindungen
EP1992621A1 (de) 2007-05-16 2008-11-19 Sanofi-Aventis Heteroarylamid-substituierte Pyrimidon-Derivate zur Behandlung von neurodegenerativen Krankheiten
EP2090578A1 (de) 2008-01-29 2009-08-19 Sanofi-Aventis Substituierte Arylamid-Diazepinopyrimidon-Derivate zur Behandlung von neurodegenerativen Erkrankungen verursacht durch eine abnormale GSK3-beta-Aktivität
EP2090579A1 (de) 2008-01-29 2009-08-19 Sanofi-Aventis Substituierte Heteroarylamiddiazepinopyrimidon-Derivate
EP2085400A1 (de) 2008-01-29 2009-08-05 Sanofi-Aventis Substituierte Heteroarylamid-Oxazepinopyrimidon-Derivate
EP2085399A1 (de) 2008-01-29 2009-08-05 Sanofi-Aventis Substituierte Arylamidoxazepinopyrimidon-Derivate
EP2138498A1 (de) 2008-06-26 2009-12-30 sanofi-aventis Substituierte trizyklische Derivate gegen neurodegenerative Erkrankungen
EP2138495A1 (de) * 2008-06-26 2009-12-30 sanofi-aventis Substituierte Pyrimido[2,1-a]isochinolin-4-on-Derivate
EP2138485A1 (de) 2008-06-26 2009-12-30 sanofi-aventis Substituierte N-Oxid-Pyrazin-Derivate
EP2138494A1 (de) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituierte Alkylpyrimidin-4-one-Derivate
EP2138488A1 (de) 2008-06-26 2009-12-30 sanofi-aventis 4-(Pyridin-4-yl)-1H-[1,3,5]Triazin-2-one-Verbindungen als GSK3-beta Hemmer zur Behandlung neurodegenerative Erkrankungen
EP2138492A1 (de) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituierte Pyrimidin-4-one-Derivate
EP2138493A1 (de) * 2008-06-26 2009-12-30 Sanofi-Aventis Substituierte Pyrimidon-Derivate
US11407748B2 (en) 2017-10-06 2022-08-09 Takeda Pharmaceutical Company Limited Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
JP7250687B2 (ja) 2017-10-06 2023-04-03 武田薬品工業株式会社 複素環化合物
CN109748914B (zh) * 2018-12-29 2021-05-25 上海珂臻医药科技有限公司 吡啶并嘧啶类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178496B (en) * 1977-12-29 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity
EP1240168B1 (de) * 1999-12-17 2005-08-31 Chiron Corporation Bizyklische inhibitoren von glycogen synthase kinase 3
EP1460076A1 (de) * 2003-03-21 2004-09-22 Sanofi-Synthelabo Substituierte 8-Perfluoro-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-on-Derivate
JO2985B1 (ar) * 2006-12-20 2016-09-05 Takeda Pharmaceuticals Co مثبطات كينازmapk/erk

Also Published As

Publication number Publication date
AR057906A1 (es) 2007-12-26
CN101312971B (zh) 2011-09-07
SI1957492T1 (sl) 2011-02-28
EA200801134A1 (ru) 2009-02-27
EP1957492B1 (de) 2010-11-10
US20110294786A1 (en) 2011-12-01
HRP20100724T1 (hr) 2011-02-28
ES2355756T3 (es) 2011-03-30
NZ568014A (en) 2011-07-29
CN101312971A (zh) 2008-11-26
MX2008006321A (es) 2009-03-23
US8148364B2 (en) 2012-04-03
JP5124471B2 (ja) 2013-01-23
RS51654B (sr) 2011-10-31
EP1790649A1 (de) 2007-05-30
PT1957492E (pt) 2011-01-24
DE602006018190D1 (de) 2010-12-23
HK1126204A1 (en) 2009-08-28
CY1111125T1 (el) 2015-06-11
US20090036427A1 (en) 2009-02-05
CA2630360A1 (en) 2007-05-24
DK1957492T3 (da) 2011-02-28
PL1957492T3 (pl) 2011-04-29
WO2007057790A3 (en) 2007-10-11
EP1957492A2 (de) 2008-08-20
KR20080070671A (ko) 2008-07-30
ZA200804335B (en) 2010-05-26
EA014918B1 (ru) 2011-04-29
JP2009516676A (ja) 2009-04-23
BRPI0618752A2 (pt) 2011-09-27
WO2007057790A2 (en) 2007-05-24
IL191213A (en) 2012-02-29

Similar Documents

Publication Publication Date Title
NL2000323A1 (nl) Pyrimidine-derivaten.
MA28824B1 (fr) Derives de pyrimidine
NL1031741A1 (nl) Purinederivaten.
MA28813B1 (fr) Derives de pyrimidine
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
EP1890703A4 (de) Pyrimidinverbindungen
DK2194043T3 (da) Fremgangsmåder
EP1724267A4 (de) Pyrimidinderivat
ATE520670T1 (de) Pyridazinderivate
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
ES2465673T9 (es) Derivados de pirimidina
ATE383361T1 (de) Pyrrazolopyrimidinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
CR10039A (es) Derivados espirocíclicos
ATE487718T1 (de) Substituierte bizyklische pyrimidonderivate
BRPI0811094A2 (pt) Derivados de heteroarilamida pirimidona
ATE449080T1 (de) 4-phenyl-6-substituierte pyrimidin-2- carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
DE502006008910D1 (de) Nockenwellenversteller

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1957492

Country of ref document: EP